461 related articles for article (PubMed ID: 27900491)
1. Treatable renal disease in children with silent lupus nephritis detected by baseline biopsy: association with serum C3 levels.
Wakiguchi H; Takei S; Kubota T; Miyazono A; Kawano Y
Clin Rheumatol; 2017 Feb; 36(2):433-437. PubMed ID: 27900491
[TBL] [Abstract][Full Text] [Related]
2. Low complements and high titre of anti-Sm antibody as predictors of histopathologically proven silent lupus nephritis without abnormal urinalysis in patients with systemic lupus erythematosus.
Ishizaki J; Saito K; Nawata M; Mizuno Y; Tokunaga M; Sawamukai N; Tamura M; Hirata S; Yamaoka K; Hasegawa H; Tanaka Y
Rheumatology (Oxford); 2015 Mar; 54(3):405-12. PubMed ID: 25183834
[TBL] [Abstract][Full Text] [Related]
3. Morphological Indexes: Can They Predict Lupus Nephritis Outcomes? A Retrospective Study.
Navarro D; Ferreira AC; Viana H; Carvalho F; Nolasco F
Acta Med Port; 2019 Oct; 32(10):635-640. PubMed ID: 31625875
[TBL] [Abstract][Full Text] [Related]
4. Does kidney biopsy in pediatric lupus patients "complement" the management and outcomes of silent lupus nephritis? Lessons learned from a pediatric cohort.
Mannemuddhu SS; Shoemaker LR; Bozorgmehri S; Borgia RE; Gupta N; Clapp WL; Zeng X; Modica RF
Pediatr Nephrol; 2023 Aug; 38(8):2669-2678. PubMed ID: 36688943
[TBL] [Abstract][Full Text] [Related]
5. Renal outcome and predictors of clinical renal involvement in patients with silent lupus nephritis.
Wada Y; Ito S; Ueno M; Nakano M; Arakawa M; Gejyo F
Nephron Clin Pract; 2004; 98(4):c105-11. PubMed ID: 15627787
[TBL] [Abstract][Full Text] [Related]
6. Silent lupus nephritis among patients with discoid lupus erythematosus.
Roujeau JC; Belghiti D; Hirbec G; Poli F; Sobel AT; Revuz J; Touraine R
Acta Derm Venereol; 1984; 64(2):160-3. PubMed ID: 6203307
[TBL] [Abstract][Full Text] [Related]
7. Frequency of class III and IV nephritis in systemic lupus erythematosus without clinical renal involvement: an analysis of predictive measures.
Wakasugi D; Gono T; Kawaguchi Y; Hara M; Koseki Y; Katsumata Y; Hanaoka M; Yamanaka H
J Rheumatol; 2012 Jan; 39(1):79-85. PubMed ID: 22089455
[TBL] [Abstract][Full Text] [Related]
8. Comparison of urinary parameters, biomarkers, and outcome of childhood systemic lupus erythematosus early onset-lupus nephritis.
Miguel DF; Terreri MT; Pereira RMR; Bonfá E; Silva CAA; Corrente JE; Magalhaes CS;
Adv Rheumatol; 2020 Feb; 60(1):10. PubMed ID: 32005292
[TBL] [Abstract][Full Text] [Related]
9. The serum levels of connective tissue growth factor in patients with systemic lupus erythematosus and lupus nephritis.
Wang FM; Yu F; Tan Y; Liu G; Zhao MH
Lupus; 2014 Jun; 23(7):655-64. PubMed ID: 24536044
[TBL] [Abstract][Full Text] [Related]
10. Lupus nephritis: the significance of serological tests at the time of biopsy.
Houssiau FA; D'Cruz D; Vianna J; Hughes GR
Clin Exp Rheumatol; 1991; 9(4):345-9. PubMed ID: 1934681
[TBL] [Abstract][Full Text] [Related]
11. [Laboratory and morphologic parameters in patients with lupus nephritis].
Rasković S; Bogić M; Perić-Popadić A; Stefanović L; Arandjelović S; Jovicić Z; Bolpacić J; Tomić-Spirić V
Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():38-41. PubMed ID: 12583312
[TBL] [Abstract][Full Text] [Related]
12. The significance of serial measurements of serum complement C3 and C4 components and DNA binding capacity in patients with lupus nephritis.
Garin EH; Donnelly WH; Shulman ST; Fernandez R; Finton C; Williams RL; Richard GA
Clin Nephrol; 1979 Oct; 12(4):148-55. PubMed ID: 315852
[TBL] [Abstract][Full Text] [Related]
13. Immunological aspects of biopsy-proven lupus nephritis in Bahraini patients with systemic lupus erythematosus.
Farid EM; Hassan AB; Abalkhail AA; El-Agroudy AE; Arrayed SA; Al-Ghareeb SM
Saudi J Kidney Dis Transpl; 2013 Nov; 24(6):1271-9. PubMed ID: 24231503
[TBL] [Abstract][Full Text] [Related]
14. Identification of biomarkers that predict response to treatment of lupus nephritis with mycophenolate mofetil or pulse cyclophosphamide.
Dall'Era M; Stone D; Levesque V; Cisternas M; Wofsy D
Arthritis Care Res (Hoboken); 2011 Mar; 63(3):351-7. PubMed ID: 21080348
[TBL] [Abstract][Full Text] [Related]
15. Silent nephritis in systemic lupus erythematosus.
Zabaleta-Lanz M; Vargas-Arenas RE; Tápanes F; Daboin I; Atahualpa Pinto J; Bianco NE
Lupus; 2003; 12(1):26-30. PubMed ID: 12587823
[TBL] [Abstract][Full Text] [Related]
16. Immuno-histological changes in lupus nephritis in female patients: a four-year study.
Qayyum A; Nagy AA
Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):658-63. PubMed ID: 18580033
[TBL] [Abstract][Full Text] [Related]
17. Study of Antichromatin Antibodies As A Marker of Lupus Activity and Lupus Nephritis.
Elsenosy FM; Mousa SG; Mohamed NA; Mohamed RH
Egypt J Immunol; 2018 Jan; 25(1):113-124. PubMed ID: 30243003
[TBL] [Abstract][Full Text] [Related]
18. Plasma cytokines as potential biomarkers of kidney damage in patients with systemic lupus erythematosus.
Pacheco-Lugo L; Sáenz-García J; Navarro Quiroz E; González Torres H; Fang L; Díaz-Olmos Y; Garavito de Egea G; Egea Bermejo E; Aroca Martínez G
Lupus; 2019 Jan; 28(1):34-43. PubMed ID: 30453818
[TBL] [Abstract][Full Text] [Related]
19. Further description of early clinically silent lupus nephritis.
Zabaleta-Lanz ME; Muñoz LE; Tapanes FJ; Vargas-Arenas RE; Daboin I; Barrios Y; Pinto JA; Bianco NE
Lupus; 2006; 15(12):845-51. PubMed ID: 17211989
[TBL] [Abstract][Full Text] [Related]
20. Do classic blood biomarkers of JSLE identify active lupus nephritis? Evidence from the UK JSLE Cohort Study.
Smith EMD; Jorgensen AL; Beresford MW;
Lupus; 2017 Oct; 26(11):1212-1217. PubMed ID: 28385126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
